DE3471929D1 - Imidazolinone derivatives as histamine h2-antagonists - Google Patents

Imidazolinone derivatives as histamine h2-antagonists

Info

Publication number
DE3471929D1
DE3471929D1 DE8484302550T DE3471929T DE3471929D1 DE 3471929 D1 DE3471929 D1 DE 3471929D1 DE 8484302550 T DE8484302550 T DE 8484302550T DE 3471929 T DE3471929 T DE 3471929T DE 3471929 D1 DE3471929 D1 DE 3471929D1
Authority
DE
Germany
Prior art keywords
histamine
antagonists
hydrogen
substituted alkyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484302550T
Other languages
English (en)
Inventor
Henry Brown Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of DE3471929D1 publication Critical patent/DE3471929D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE8484302550T 1983-04-27 1984-04-13 Imidazolinone derivatives as histamine h2-antagonists Expired DE3471929D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838311443A GB8311443D0 (en) 1983-04-27 1983-04-27 Chemical compounds

Publications (1)

Publication Number Publication Date
DE3471929D1 true DE3471929D1 (de) 1988-07-14

Family

ID=10541762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484302550T Expired DE3471929D1 (de) 1983-04-27 1984-04-13 Imidazolinone derivatives as histamine h2-antagonists

Country Status (17)

Country Link
US (1) US4567176A (de)
EP (1) EP0132914B1 (de)
JP (1) JPS60501207A (de)
KR (1) KR840008330A (de)
AT (1) ATE34978T1 (de)
DE (1) DE3471929D1 (de)
ES (1) ES8505668A1 (de)
FI (1) FI845095A0 (de)
GB (1) GB8311443D0 (de)
GR (1) GR81941B (de)
HU (1) HUT34744A (de)
IL (1) IL71639A0 (de)
NO (1) NO845172L (de)
PT (1) PT78498B (de)
WO (1) WO1984004304A1 (de)
ZA (1) ZA843088B (de)
ZW (1) ZW6784A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
TW221689B (de) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
GB9611046D0 (en) * 1996-05-25 1996-07-31 Wivenhoe Techn Ltd Pharmacological compounds
CN1972914A (zh) 2004-03-31 2007-05-30 詹森药业有限公司 作为组胺h3受体配合体的非咪唑杂环化合物
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CN105712977B (zh) 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
GR79384B (de) * 1982-08-20 1984-10-22 Hoechst Uk Ltd

Also Published As

Publication number Publication date
KR840008330A (ko) 1984-12-14
FI845095L (fi) 1984-12-21
ES531933A0 (es) 1985-06-01
ES8505668A1 (es) 1985-06-01
EP0132914A3 (en) 1985-12-27
ZW6784A1 (en) 1985-04-17
ZA843088B (en) 1985-02-27
WO1984004304A1 (en) 1984-11-08
FI845095A0 (fi) 1984-12-21
PT78498B (en) 1986-06-02
GR81941B (de) 1984-12-12
GB8311443D0 (en) 1983-06-02
NO845172L (no) 1984-12-21
IL71639A0 (en) 1984-07-31
ATE34978T1 (de) 1988-06-15
PT78498A (en) 1984-05-01
US4567176A (en) 1986-01-28
JPS60501207A (ja) 1985-08-01
HUT34744A (en) 1985-04-28
EP0132914A2 (de) 1985-02-13
EP0132914B1 (de) 1988-06-08

Similar Documents

Publication Publication Date Title
DE3471929D1 (de) Imidazolinone derivatives as histamine h2-antagonists
ATE78163T1 (de) Stickstoff enthaltende heterozyklische verbindungen.
SE8303913D0 (sv) Heterocykliska foreningar
ATE40552T1 (de) Aminopyrimidinon-derivate als histamin-h2antagonisten.
FI864737A (fi) Nya basiskt substituerade pyridinfoereningar, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI842432A0 (fi) Amidinderivat av 2-substituerad 4-fenyl-imidazoler, foerfarande foer deras framstaellning och deras farmaceutiska anvaendning.
ATE5724T1 (de) Guanidinverbindungen, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
EP0140466A3 (de) Pyrimidinon-Derivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
IT1210914B (it) Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
ES8201994A1 (es) Procedimiento para la obtencion de nuevos derivados piridi- nicos de interes farmacologico
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee